Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- Peregrine Pharmaceuticals (NASDAQ:PPHM) is a biopharmaceutical company that is engaged in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
The lead product candidates of Peregrine Pharmaceuticals in development include Bavituximab which is a phosphatidylserine (PS) targeting agent that completed Phase IIb second-line non-small cell lung cancer trial for the treatment of solid tumors and Cotara which is a DNA/histone-targeting antibody that completed Phase II multicenter trial for the treatment of brain cancer. Peregrine Pharmaceuticals is also conducting various other trials with bavituximab in combination with other therapies in multiple oncology indications as potential secondary indications for bavituximab.
The has license, research and development agreements with the University of Texas Southwestern Medical Center, Genentech, Inc., Avanir Pharmaceuticals, Inc., Lonza Biologics; Affitech A/S, UTSWMC, and Merck KGaA. The company was founded in 1981 and is based in Tustin, California.
To find out what OTCMAGIC projects for Peregrine Pharmaceuticals for both short term and long term please click here: PPHM
OTCMAGIC spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 visitors a month and growing rapidly OTCMAGIC is the hottest thing in OTC Picks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)